Caribou Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBU and other ETFs, options, and stocks.

About CRBU

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.

CEO

Rachel E. Haurwitz

CEORachel E. Haurwitz

Employees

147

Employees147

Headquarters

Berkeley, California

HeadquartersBerkeley, California

Founded

2011

Founded2011

Employees

147

Employees147

CRBU Key Statistics

Market cap

110.68M

Market cap110.68M

Price-Earnings ratio

-0.73

Price-Earnings ratio-0.73

Dividend yield

—

Dividend yield—

Average volume

1.38M

Average volume1.38M

High today

—

High today—

Low today

—

Low today—

Open price

$1.26

Open price$1.26

Volume

0.00

Volume0.00

52 Week high

$3.00

52 Week high$3.00

52 Week low

$0.66

52 Week low$0.66

Analyst ratings

78%

of 9 ratings

Buy

77.8%

Hold

22.2%

Sell

People also own

Based on the portfolios of people who own CRBU. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

Intellia Therapeutics